Erythrokeratodermia variabilis
|
0.900 |
Biomarker
|
disease |
CLINGEN |
Identification of a novel mutation R42P in the gap junction protein beta-3 associated with autosomal dominant erythrokeratoderma variabilis.
|
10594760 |
1999 |
Erythrokeratodermia variabilis
|
0.900 |
Biomarker
|
disease |
BEFREE |
Despite slight differences, phenotypes of EKV Mendes Da Costa (Cx31) and EKV Cram-Mevorah (Cx30.3) show major clinical overlap and both Cx30.3 and Cx31 are expressed in the upper epidermal layers.
|
14583444 |
2003 |
Erythrokeratodermia variabilis
|
0.900 |
Biomarker
|
disease |
BEFREE |
Mutations in the GJB3 gene, encoding the gap junction protein connexin 31 (Cx31), have been pathogenically linked to erythrokeratodermia variabilis and nonsyndromic autosomal recessive or dominant hereditary hearing impairment.
|
15131355 |
2004 |
Erythrokeratodermia variabilis
|
0.900 |
Biomarker
|
disease |
CLINGEN |
Erythrokeratodermia variabilis: first Japanese case documenting GJB3 mutation.
|
23442023 |
2013 |
Erythrokeratodermia variabilis
|
0.900 |
Biomarker
|
disease |
CLINGEN |
A sporadic elder case of erythrokeratodermia variabilis with a single base-pair transversion in GJB3 gene successfully treated with systemic vitamin A derivative.
|
25297803 |
2014 |
Erythrokeratodermia variabilis
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
All families with EKV show mapping to chromosome 1p34-p35, and mutations in the gene for connexin 31 (Cx31) have been reported in some but not all families.
|
11017804 |
2000 |
Erythrokeratodermia variabilis
|
0.900 |
Biomarker
|
disease |
CLINGEN |
We also show that a mutation of human Connexin 31, which causes erythrokeratoderma variabilis, induces ER stress and p63-dependent epidermal apoptosis in the zebrafish embryo, thus implicating this pathway in the pathogenesis of inherited disease.
|
21920315 |
2011 |
Erythrokeratodermia variabilis
|
0.900 |
Biomarker
|
disease |
CLINGEN |
The study suggests that Cx31 mutant proteins are un/misfolded to cause EKV likely via an AP-1-mediated mechanism and identifies a small molecule with therapeutic potential of the disease.
|
26251042 |
2015 |
Erythrokeratodermia variabilis
|
0.900 |
Biomarker
|
disease |
CTD_human |
Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis.
|
9843209 |
1998 |
Erythrokeratodermia variabilis
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Identification of a novel mutation R42P in the gap junction protein beta-3 associated with autosomal dominant erythrokeratoderma variabilis.
|
10594760 |
1999 |
Erythrokeratodermia variabilis
|
0.900 |
Biomarker
|
disease |
CLINGEN |
Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis.
|
9843209 |
1998 |
Erythrokeratodermia variabilis
|
0.900 |
Biomarker
|
disease |
CLINGEN |
Expression of a connexin31 mutation causing erythrokeratodermia variabilis is lethal for HeLa cells.
|
12176042 |
2002 |
Erythrokeratodermia variabilis
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
A novel, recurrent GJB3 mutation (625C-->T; L209F) was identified in the family with EKV and in the unrelated sporadic case.
|
15948974 |
2005 |
Erythrokeratodermia variabilis
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Only the proband and her unaffected mother exhibited the GJB3 mutation, which is in the same amino acid of a known Erythrokeratodermia variabilis mutation.
|
29044474 |
2018 |
Erythrokeratodermia variabilis
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Erythrokeratodermia variabilis et progressiva (EKV-P) is caused by mutations in either the GJB3 (Cx31) or GJB4 genes (Cx30.3).
|
29570224 |
2019 |